Sanofi Genzyme is partnering with PerkinElmer Genomics to offer a complimentary genetic testing program called The Lantern Project. This program will provide diagnostic testing for the following lysosomal storage disorders:
- Fabry disease
- Pompe disease
- Gaucher disease
- Niemann─Pick Type A and B (ASMD)
- Mucopolysaccharidosis I (MPS I) and Other MPS Disorders
- Focused Neuromuscular Disease Panel
To order collection kits for the Lantern Project click here
For additional information about the Lantern Project click here
Ultragenyx and PerkinElmer Genomics have partnered to offer sponsored MPS panel testing to patients who are suspected of having MPS disorder, or who have been clinically diagnosed with MPS and need confirmatory testing. For Health Care Professionals interested in learning more about the program or ordering collection kits please use links below:
To order collection kits for Ultragenyx sponsored testing click here.
For additional information about the Ultragenyx sponsored testing program click here.
Decode Duchenne provides diagnostic testing for Duchenne and Becker muscular dystrophy. Decode Duchenne is a collaborative partnership between Parent Project Muscular Dystrophy (PPMD), industry partners NS Pharma, Sarepta Therapeutics, PTC Therapeutics and Vertex Pharmaceuticals, and PerkinElmer Genomics.
For additional information about the Decode Duchenne testing program click here.
Aceragen is partnering with PerkinElmer Genomics to support no-cost genetic testing of the ASAH1 gene to support the diagnosis of patients with acid ceramidase deficiency. Aceragen is a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases.
For additional information about the ASAH1 Gene Sequencing sponsored testing program click here.
Identifying the underlying cause of your patient’s chronic anemia can make a big difference to your patient’s life. That’s why Agios Pharmaceuticals has partnered with PerkinElmer Genomics to offer Anemia ID: a free genetic testing program. Anemia ID provides a next-generation sequencing (NGS) panel for a wide range of rare hereditary anemias.
For additional information about the ANEMIA ID sponsored testing program click here.